Hydrogen-bond donors are seen to cause more problems
for drug designers
than hydrogen-bond acceptors. Most of the polarity in drug-like compounds
comes from hydrogen-bond acceptors since they typically exceed the
hydrogen-bond donors in number and are more heavily solvated on an
individual basis. The implications of this polarity imbalance for
optimization of permeability and aqueous solubility are discussed.
A factor that should be considered in optimization of ligand recognition
by targets is that the presence of a hydrogen-bond donor generally
implies that a hydrogen-bond acceptor is also present (but not vice
versa). Frustrated solvation and secondary electrostatic interactions
result from aligned hydrogen-bond donors and acceptors, and the design
opportunities presented by these phenomena are discussed. Hydrogen-bond
donors based on oxygen, nitrogen and carbon are compared as target
recognition elements, and halogen- and chalcogen-bond donors are discussed
as hydrogen-bond donor equivalents.